Jim Cramer expects a relatively quiet week for Wall Street, with only a few major corporate events left on the calendar before September ends.
Much of the month’s major macroeconomic news has already passed, with the Federal Reserve, European...
Novo Nordisk (NVO) rebranded itself as simply “Novo” on Monday, unveiling a new corporate culture framework as the Danish drugmaker tries to close a widening gap with rival Eli Lilly in the obesity drug market.
CEO Mike Doustdar told CNBC the...
Hair loss biotechs are racing to deliver the first new baldness treatments in nearly three decades, and investors are positioning for the payoff.
Veradermics, Absci, and Cosmo Pharmaceuticals are advancing a pill, an injection, and a topical drug...
Eli Lilly is one of the most popular names today in America’s weight-loss and diabetes drug market. Its drugs delivered an average weight loss of 28.3% in a Phase 3 trial, approaching results historically associated with bariatric surgery and...
L&C Bio Co., Ltd. (290650.KQ) shares jumped nearly 12% Thursday on plans for an Ozempic face fix made from donated human fat.
The KOSDAQ-listed stock reached 64,600 won intraday, up 11.76%, per Yahoo Finance data, extending a five-day gain of...
McDonald’s (MCD) stock fell to $264.09 on July 15, its lowest level in two years. The drop extends the decline to 22.45% from the March record high of $341.75, placing the stock in an official bear market.
A wave of analyst downgrades hit the...
